Real-time enrollment status for this diffuse large b-cell lymphoma clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 11:13 AM UTC
| NCT Number | NCT06806033 |
| Recruiting Status | Recruiting |
| Condition | Diffuse Large B-Cell Lymphoma |
| Phase | PHASE2 |
| Target Enrollment | 100 participants |
| Active Locations | 33 sites in the US |
| Sponsor | Hoffmann-La Roche |
| Last Updated on CT.gov | June 23, 2026 (3 weeks ago) |
As of July 18, 2026: Clinical trial NCT06806033 is currently recruiting participants. This phase2 study for diffuse large b-cell lymphoma is actively seeking new participants at 33 locations across the United States. The study is sponsored by Hoffmann-La Roche. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06806033 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 33 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06806033 was last updated 3 weeks ago (June 23, 2026). HelloStudys verifies this status automatically.